Placeholder Banner

BIO Statement on the Status of the U.S.-China 100-Day Plan

July 17, 2017

Washington, D.C. (July 17, 2017) – The Biotechnology Innovation Organization (BIO) today issued the following statement on the status of the U.S.-China 100-day plan:

“The Biotechnology Innovation Organization remains focused on achieving full success as part of the U.S.-China 100-day plan. To date, the Chinese Ministry of Agriculture has approved four of the eight products identified as part of the “Initial Results of the 100-day Action Plan,” released on May 11, 2017. This agreement established a process to ensure that the Chinese National Biosafety Committee (NBC) and Ministry of Agriculture (MOA) could satisfy any remaining technical questions related to the intended use of the products in a timely manner and to hold NBC meetings as frequently and as soon as possible to finalize the reviews.   

“As the U.S. and Chinese governments meet this week as part of the U.S.-China Comprehensive Economic Dialogue, industry urges the governments to provide additional clarity regarding the implementation of this agreement to ensure that the process is completed and all eight products are approved without delay. On average, the eight products have been pending Chinese approval for five years and already have been approved in multiple markets around the world.”

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Upcoming BIO Events
BIO World Congress on Industrial Biotechnology
July 23 - 26, 2017
Montréal, Canada

Discover More
Collaboration has evolved for more than two decades   
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Joe Biden yesterday suggesting the establishment of a COVID Global Strategy for Harnessing Access Reaching Everyone (SHARE)…